We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGC
3426
DELISTED
Altimeter Growth Corp
AGC
-18,343
Closed -$215K
IACB.U
3427
DELISTED
ION Acquisition Corp 2 Ltd. Units, each consisting of one Class A ordinary share and one-eighth of o
IACB.U
-100,000
Closed -$1.02M
CVA
3428
DELISTED
Covanta Holding Corporation
CVA
-11,252
Closed -$156K
XLRN
3429
DELISTED
Acceleron Pharma
XLRN
-6,542
Closed -$887K
LIII.U
3430
DELISTED
Leo Holdings III Corp Units, each consisting of one Class A ordinary share, and one-fifth of one red
LIII.U
-1,000,000
Closed -$9.8M
FLXN
3431
DELISTED
Flexion Therapeutics, Inc.
FLXN
-124,512
Closed -$1.11M
SWBK.U
3432
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
-56,025
Closed -$570K
RTPYU
3433
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
-1,000,000
Closed -$10M
SIC
3434
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
-48,617
Closed -$350K
KURIU
3435
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
-928,364
Closed -$9.17M
BOWX
3436
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
-410,011
Closed -$4.79M
LEGOU
3437
DELISTED
Legato Merger Corp. Units
LEGOU
-18,802
Closed -$190K
CSOD
3438
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-22,175
Closed -$966K
NNA
3439
DELISTED
Navios Maritime Acquisition Corporation
NNA
-25,138
Closed -$102K
GPX
3440
DELISTED
GP Strategies Corp.
GPX
-10,626
Closed -$185K
ARD
3441
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
-25,713
Closed -$653K
KCAC.U
3442
DELISTED
Kensington Capital Acquisition Corp. II Units, each consisting of one share of Class A common stock,
KCAC.U
-100,000
Closed -$1.03M
DMYI.WS
3443
CALL
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
-92,634
Closed -$998K
SRNGU
3444
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
-1,000,000
Closed -$10.1M
CENHU
3445
DELISTED
Centricus Acquisition Corp. Unit
CENHU
-1,000,000
Closed -$9.95M
SNPR.WS
3446
CALL
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
-289,559
Closed -$3.17M
CLOVW
3447
CALL
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
-254,613
Closed -$1.93M
DGNR.WS
3448
CALL
DELISTED
Dragoneer Growth Opportunities Corp. Redeemable warrants, each whole warrant exercisable for one Cla
DGNR.WS
-83,538
Closed -$848K
NEBCW
3449
CALL
DELISTED
Nebula Caravel Acquisition Corp. Warrant
NEBCW
-79,993
Closed -$794K
NEBC
3450
DELISTED
Nebula Caravel Acquisition Corp. Class A Common Stock
NEBC
-399,965
Closed -$3.97M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.